Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ABT
ABT logo

ABT

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ABT News

Surging Demand for GLP-1 Drugs Benefits Medical Device Companies

15h agoFool

Dividend Kings: Steady Growth Investment Choices

18h agoFool

Long-Term Investment Strategy in Healthcare Sector

2d agoFool

Omnipod 5 Insulin Delivery System Launches in Spain

2d agoYahoo Finance

AbbVie Q1 Earnings Beat Expectations, Market Reacts Positively

4d agoYahoo Finance

Schwab U.S. Dividend ETF Shows Strong Performance

5d agoNASDAQ.COM

The Potential and Returns of Dividend Investing

5d agoFool

Investment Comparison: Abbott vs. Intuitive Surgical

6d agoFool

Baird Initiates Outperform Rating on Abbott Laboratories

6d agoseekingalpha

Latest Wall Street Rating Updates

Jul 01 2026CNBC

Analysis of Three Major High Dividend ETFs

Jun 30 2026NASDAQ.COM

Stable Passive Income Source: High Dividend ETFs

Jun 30 2026Fool

Defensive Dividend Stock Investment Opportunities Amid Market Concerns

Jun 29 2026Fool

U.S. Justice Department Closes Criminal Probe into Abbott Laboratories

Jun 29 2026seekingalpha

Abbott Laboratories: A Safe Harbor Stock Choice

Jun 28 2026Fool

Abbott Laboratories: A Preferred Defensive Investment

Jun 28 2026NASDAQ.COM